• Publications
  • Influence
Costs and quality of life of patients with multiple sclerosis in Europe
Objective: To assess overall resource consumption, work capacity and quality of life of patients with multiple sclerosis in nine European countries. Methods: Information on resource consumptionExpand
  • 319
  • 28
Costs and quality of life in multiple sclerosis
Objective: To estimate current costs and quality of life (utility) of patients treated with disease modifying drugs (DMDs) in the United States, and to investigate the effect of disease severity onExpand
  • 222
  • 13
Costs and quality of life of multiple sclerosis in Spain
This cost-of-illness analysis is based on information from 1.848 patients in Spain and is part of a Europe-wide study on the costs of multiple sclerosis. The objective was to analyze the costs andExpand
  • 115
  • 11
Costs and quality of life in multiple sclerosis
We performed a cross-sectional, “bottom-up” observational study of resource use, costs, and quality of life in patients with multiple sclerosis (MS) in Germany. Six centers participated in the study.Expand
  • 163
  • 10
  • PDF
The burden of rheumatoid arthritis and access to treatment: health burden and costs
As part of the study “The burden of rheumatoid arthritis and patient access to treatment”, this paper reviews evidence on the health burden of rheumatoid arthritis (RA) in terms of morbidity (DALYs),Expand
  • 199
  • 10
Costs and quality of life of multiple sclerosis in the United Kingdom
This cost-of-illness analysis for the United Kingdom is part of a Europe-wide study on the costs of multiple sclerosis (MS). The objective was to analyze the costs and quality of life (utility)Expand
  • 83
  • 10
Costs and quality of life of multiple sclerosis in Sweden
The study objective was to analyse the costs and quality of life (QOL) of multiple sclerosis (MS) related to disease severity in Sweden as part of a study in nine European countries. Information onExpand
  • 98
  • 10
Costs and quality of life of multiple sclerosis in Italy
This cost-of-illness analysis based on information from 921 patients in Italy is part of a Europe-wide cost-of-illness study in multiple sclerosis (MS). The objective was to analyze the costs andExpand
  • 51
  • 10
Economic consequences of the progression of rheumatoid arthritis in Sweden.
OBJECTIVE To develop a simulation model for analysis of the cost-effectiveness of treatments that affect the progression of rheumatoid arthritis (RA). METHODS The Markov model was developed on theExpand
  • 181
  • 9
TNF inhibitors in the treatment of rheumatoid arthritis in clinical practice: costs and outcomes in a follow up study of patients with RA treated with etanercept or infliximab in southern Sweden.
OBJECTIVES To evaluate costs, benefits, and cost effectiveness of tumour necrosis factor inhibitor treatment over one year in routine clinical practice. MATERIALS AND METHODS At four rheumatologyExpand
  • 144
  • 9
  • PDF